产品展示
H3N2 New-York/重组血凝素A型流感病毒H3N2病毒New York 55/04
点击次数：204发布时间：2012/11/6 21:02:36
更新日期：2024/10/16 16:00:55
所 在 地：美洲
产品型号：
优质供应
详细内容
慧嘉生物您实验身边的好伙伴
为客户提供“品质的产品”和“*优质的服务”
AssayBiotech CUSABIO Immunoway Santa Abcam Cst jackson Pierce Sigma Amresco Qiagen Cayman abnova millipore invitrogen merk ebioscience prospec
欢迎广大客户咨询，另有大量宣传海报和小礼品赠送。
Q Q：
H3N2 New-York/重组血凝素A型流感病毒H3N2病毒New York 55/04
产品编号：IHA-011
产品规格：2μg/10μg/100μg
Introduction H3N2 is a subtype of the influenza A virus. Its name derives from the forms of the two kinds of proteinson the surface of its coat, hemagglutinin（H） ａnd neuraminidase（N）. H3N2 exchanges genes for internal proteins with other influenza subtypes. H3N2 has tended to dominate in prevalence over H1N1, H1N2, ａnd influenza B. H3N2 strain descended from H2N2by antigenic shift, in which genes from multiple subtypes re-assorted to form a new virus. Both the H2N2and H3N2 strains contained genesfrom avian influenzaviruses. Description Recombinant Full-Length H3N2 A/New York/55/04 is glycosylated with N-linked sugars, produced using baculovirus vectors in insect cells ａnd its Mw is 70,000 dalton. Source Baculovirus Insect Cells. Physical Appearance Sterile Filtered colorless solution FormulationThe Recombinant H3N2 A/New-York/55/04 solution contains 30mM Sodium phosphate, pH 7.4 ａnd 500mM NaCl. Stability H3N2 A/New-York/55/04 Recombinant should be stored at 4°C. Immunological Activity Western-Blot 0.1μg -1μg per strip, ELISA 1μg/Well. Purity Greater than 90.0% as determined by SDS-PAGE. Usage ProSpec＇s products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
H3N2 New-York/重组血凝素A型流感病毒H3N2病毒New York 55/04
产品编号：IHA-011
产品规格：2μg/10μg/100μg
Introduction H3N2 is a subtype of the influenza A virus. Its name derives from the forms of the two kinds of proteinson the surface of its coat, hemagglutinin（H） ａnd neuraminidase（N）. H3N2 exchanges genes for internal proteins with other influenza subtypes. H3N2 has tended to dominate in prevalence over H1N1, H1N2, ａnd influenza B. H3N2 strain descended from H2N2by antigenic shift, in which genes from multiple subtypes re-assorted to form a new virus. Both the H2N2and H3N2 strains contained genesfrom avian influenzaviruses. Description Recombinant Full-Length H3N2 A/New York/55/04 is glycosylated with N-linked sugars, produced using baculovirus vectors in insect cells ａnd its Mw is 70,000 dalton. Source Baculovirus Insect Cells. Physical Appearance Sterile Filtered colorless solution FormulationThe Recombinant H3N2 A/New-York/55/04 solution contains 30mM Sodium phosphate, pH 7.4 ａnd 500mM NaCl. Stability H3N2 A/New-York/55/04 Recombinant should be stored at 4°C. Immunological Activity Western-Blot 0.1μg -1μg per strip, ELISA 1μg/Well. Purity Greater than 90.0% as determined by SDS-PAGE. Usage ProSpec＇s products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
H3N2 New-York/重组血凝素A型流感病毒H3N2病毒New York 55/04
产品编号：IHA-011
产品规格：2μg/10μg/100μg
Introduction H3N2 is a subtype of the influenza A virus. Its name derives from the forms of the two kinds of proteinson the surface of its coat, hemagglutinin（H） ａnd neuraminidase（N）. H3N2 exchanges genes for internal proteins with other influenza subtypes. H3N2 has tended to dominate in prevalence over H1N1, H1N2, ａnd influenza B. H3N2 strain descended from H2N2by antigenic shift, in which genes from multiple subtypes re-assorted to form a new virus. Both the H2N2and H3N2 strains contained genesfrom avian influenzaviruses. Description Recombinant Full-Length H3N2 A/New York/55/04 is glycosylated with N-linked sugars, produced using baculovirus vectors in insect cells ａnd its Mw is 70,000 dalton. Source Baculovirus Insect Cells. Physical Appearance Sterile Filtered colorless solution FormulationThe Recombinant H3N2 A/New-York/55/04 solution contains 30mM Sodium phosphate, pH 7.4 ａnd 500mM NaCl. Stability H3N2 A/New-York/55/04 Recombinant should be stored at 4°C. Immunological Activity Western-Blot 0.1μg -1μg per strip, ELISA 1μg/Well. Purity Greater than 90.0% as determined by SDS-PAGE. Usage ProSpec＇s products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
H3N2 New-York/重组血凝素A型流感病毒H3N2病毒New York 55/04
产品编号：IHA-011
产品规格：2μg/10μg/100μg
Introduction H3N2 is a subtype of the influenza A virus. Its name derives from the forms of the two kinds of proteinson the surface of its coat, hemagglutinin（H） ａnd neuraminidase（N）. H3N2 exchanges genes for internal proteins with other influenza subtypes. H3N2 has tended to dominate in prevalence over H1N1, H1N2, ａnd influenza B. H3N2 strain descended from H2N2by antigenic shift, in which genes from multiple subtypes re-assorted to form a new virus. Both the H2N2and H3N2 strains contained genesfrom avian influenzaviruses. Description Recombinant Full-Length H3N2 A/New York/55/04 is glycosylated with N-linked sugars, produced using baculovirus vectors in insect cells ａnd its Mw is 70,000 dalton. Source Baculovirus Insect Cells. Physical Appearance Sterile Filtered colorless solution FormulationThe Recombinant H3N2 A/New-York/55/04 solution contains 30mM Sodium phosphate, pH 7.4 ａnd 500mM NaCl. Stability H3N2 A/New-York/55/04 Recombinant should be stored at 4°C. Immunological Activity Western-Blot 0.1μg -1μg per strip, ELISA 1μg/Well. Purity Greater than 90.0% as determined by SDS-PAGE. Usage ProSpec＇s products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
H3N2 New-York/重组血凝素A型流感病毒H3N2病毒New York 55/04
产品编号：IHA-011
产品规格：2μg/10μg/100μg
Introduction H3N2 is a subtype of the influenza A virus. Its name derives from the forms of the two kinds of proteinson the surface of its coat, hemagglutinin（H） ａnd neuraminidase（N）. H3N2 exchanges genes for internal proteins with other influenza subtypes. H3N2 has tended to dominate in prevalence over H1N1, H1N2, ａnd influenza B. H3N2 strain descended from H2N2by antigenic shift, in which genes from multiple subtypes re-assorted to form a new virus. Both the H2N2and H3N2 strains contained genesfrom avian influenzaviruses. Description Recombinant Full-Length H3N2 A/New York/55/04 is glycosylated with N-linked sugars, produced using baculovirus vectors in insect cells ａnd its Mw is 70,000 dalton. Source Baculovirus Insect Cells. Physical Appearance Sterile Filtered colorless solution FormulationThe Recombinant H3N2 A/New-York/55/04 solution contains 30mM Sodium phosphate, pH 7.4 ａnd 500mM NaCl. Stability H3N2 A/New-York/55/04 Recombinant should be stored at 4°C. Immunological Activity Western-Blot 0.1μg -1μg per strip, ELISA 1μg/Well. Purity Greater than 90.0% as determined by SDS-PAGE. Usage ProSpec＇s products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
H3N2 New-York/重组血凝素A型流感病毒H3N2病毒New York 55/04
产品编号：IHA-011
产品规格：2μg/10μg/100μg
Introduction H3N2 is a subtype of the influenza A virus. Its name derives from the forms of the two kinds of proteinson the surface of its coat, hemagglutinin（H） ａnd neuraminidase（N）. H3N2 exchanges genes for internal proteins with other influenza subtypes. H3N2 has tended to dominate in prevalence over H1N1, H1N2, ａnd influenza B. H3N2 strain descended from H2N2by antigenic shift, in which genes from multiple subtypes re-assorted to form a new virus. Both the H2N2and H3N2 strains contained genesfrom avian influenzaviruses. Description Recombinant Full-Length H3N2 A/New York/55/04 is glycosylated with N-linked sugars, produced using baculovirus vectors in insect cells ａnd its Mw is 70,000 dalton. Source Baculovirus Insect Cells. Physical Appearance Sterile Filtered colorless solution FormulationThe Recombinant H3N2 A/New-York/55/04 solution contains 30mM Sodium phosphate, pH 7.4 ａnd 500mM NaCl. Stability H3N2 A/New-York/55/04 Recombinant should be stored at 4°C. Immunological Activity Western-Blot 0.1μg -1μg per strip, ELISA 1μg/Well. Purity Greater than 90.0% as determined by SDS-PAGE. Usage ProSpec＇s products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
H3N2 New-York/重组血凝素A型流感病毒H3N2病毒New York 55/04
产品编号：IHA-011
产品规格：2μg/10μg/100μg
Introduction H3N2 is a subtype of the influenza A virus. Its name derives from the forms of the two kinds of proteinson the surface of its coat, hemagglutinin（H） ａnd neuraminidase（N）. H3N2 exchanges genes for internal proteins with other influenza subtypes. H3N2 has tended to dominate in prevalence over H1N1, H1N2, ａnd influenza B. H3N2 strain descended from H2N2by antigenic shift, in which genes from multiple subtypes re-assorted to form a new virus. Both the H2N2and H3N2 strains contained genesfrom avian influenzaviruses. Description Recombinant Full-Length H3N2 A/New York/55/04 is glycosylated with N-linked sugars, produced using baculovirus vectors in insect cells ａnd its Mw is 70,000 dalton. Source Baculovirus Insect Cells. Physical Appearance Sterile Filtered colorless solution FormulationThe Recombinant H3N2 A/New-York/55/04 solution contains 30mM Sodium phosphate, pH 7.4 ａnd 500mM NaCl. Stability H3N2 A/New-York/55/04 Recombinant should be stored at 4°C. Immunological Activity Western-Blot 0.1μg -1μg per strip, ELISA 1μg/Well. Purity Greater than 90.0% as determined by SDS-PAGE. Usage ProSpec＇s products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
H3N2 New-York/重组血凝素A型流感病毒H3N2病毒New York 55/04
产品编号：IHA-011
产品规格：2μg/10μg/100μg
Introduction H3N2 is a subtype of the influenza A virus. Its name derives from the forms of the two kinds of proteinson the surface of its coat, hemagglutinin（H） ａnd neuraminidase（N）. H3N2 exchanges genes for internal proteins with other influenza subtypes. H3N2 has tended to dominate in prevalence over H1N1, H1N2, ａnd influenza B. H3N2 strain descended from H2N2by antigenic shift, in which genes from multiple subtypes re-assorted to form a new virus. Both the H2N2and H3N2 strains contained genesfrom avian influenzaviruses. Description Recombinant Full-Length H3N2 A/New York/55/04 is glycosylated with N-linked sugars, produced using baculovirus vectors in insect cells ａnd its Mw is 70,000 dalton. Source Baculovirus Insect Cells. Physical Appearance Sterile Filtered colorless solution FormulationThe Recombinant H3N2 A/New-York/55/04 solution contains 30mM Sodium phosphate, pH 7.4 ａnd 500mM NaCl. Stability H3N2 A/New-York/55/04 Recombinant should be stored at 4°C. Immunological Activity Western-Blot 0.1μg -1μg per strip, ELISA 1μg/Well. Purity Greater than 90.0% as determined by SDS-PAGE. Usage ProSpec＇s products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
H3N2 New-York/重组血凝素A型流感病毒H3N2病毒New York 55/04
产品编号：IHA-011
产品规格：2μg/10μg/100μg
Introduction H3N2 is a subtype of the influenza A virus. Its name derives from the forms of the two kinds of proteinson the surface of its coat, hemagglutinin（H） ａnd neuraminidase（N）. H3N2 exchanges genes for internal proteins with other influenza subtypes. H3N2 has tended to dominate in prevalence over H1N1, H1N2, ａnd influenza B. H3N2 strain descended from H2N2by antigenic shift, in which genes from multiple subtypes re-assorted to form a new virus. Both the H2N2and H3N2 strains contained genesfrom avian influenzaviruses. Description Recombinant Full-Length H3N2 A/New York/55/04 is glycosylated with N-linked sugars, produced using baculovirus vectors in insect cells ａnd its Mw is 70,000 dalton. Source Baculovirus Insect Cells. Physical Appearance Sterile Filtered colorless solution FormulationThe Recombinant H3N2 A/New-York/55/04 solution contains 30mM Sodium phosphate, pH 7.4 ａnd 500mM NaCl. Stability H3N2 A/New-York/55/04 Recombinant should be stored at 4°C. Immunological Activity Western-Blot 0.1μg -1μg per strip, ELISA 1μg/Well. Purity Greater than 90.0% as determined by SDS-PAGE. Usage ProSpec＇s products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
H3N2 New-York/重组血凝素A型流感病毒H3N2病毒New York 55/04
产品编号：IHA-011
产品规格：2μg/10μg/100μg
Introduction H3N2 is a subtype of the influenza A virus. Its name derives from the forms of the two kinds of proteinson the surface of its coat, hemagglutinin（H） ａnd neuraminidase（N）. H3N2 exchanges genes for internal proteins with other influenza subtypes. H3N2 has tended to dominate in prevalence over H1N1, H1N2, ａnd influenza B. H3N2 strain descended from H2N2by antigenic shift, in which genes from multiple subtypes re-assorted to form a new virus. Both the H2N2and H3N2 strains contained genesfrom avian influenzaviruses. Description Recombinant Full-Length H3N2 A/New York/55/04 is glycosylated with N-linked sugars, produced using baculovirus vectors in insect cells ａnd its Mw is 70,000 dalton. Source Baculovirus Insect Cells. Physical Appearance Sterile Filtered colorless solution FormulationThe Recombinant H3N2 A/New-York/55/04 solution contains 30mM Sodium phosphate, pH 7.4 ａnd 500mM NaCl. Stability H3N2 A/New-York/55/04 Recombinant should be stored at 4°C. Immunological Activity Western-Blot 0.1μg -1μg per strip, ELISA 1μg/Well. Purity Greater than 90.0% as determined by SDS-PAGE. Usage ProSpec＇s products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
H3N2 New-York/重组血凝素A型流感病毒H3N2病毒New York 55/04
产品编号：IHA-011
产品规格：2μg/10μg/100μg
Introduction H3N2 is a subtype of the influenza A virus. Its name derives from the forms of the two kinds of proteinson the surface of its coat, hemagglutinin（H） ａnd neuraminidase（N）. H3N2 exchanges genes for internal proteins with other influenza subtypes. H3N2 has tended to dominate in prevalence over H1N1, H1N2, ａnd influenza B. H3N2 strain descended from H2N2by antigenic shift, in which genes from multiple subtypes re-assorted to form a new virus. Both the H2N2and H3N2 strains contained genesfrom avian influenzaviruses. Description Recombinant Full-Length H3N2 A/New York/55/04 is glycosylated with N-linked sugars, produced using baculovirus vectors in insect cells ａnd its Mw is 70,000 dalton. Source Baculovirus Insect Cells. Physical Appearance Sterile Filtered colorless solution FormulationThe Recombinant H3N2 A/New-York/55/04 solution contains 30mM Sodium phosphate, pH 7.4 ａnd 500mM NaCl. Stability H3N2 A/New-York/55/04 Recombinant should be stored at 4°C. Immunological Activity Western-Blot 0.1μg -1μg per strip, ELISA 1μg/Well. Purity Greater than 90.0% as determined by SDS-PAGE. Usage ProSpec＇s products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
H3N2 New-York/重组血凝素A型流感病毒H3N2病毒New York 55/04
产品编号：IHA-011
产品规格：2μg/10μg/100μg
Introduction H3N2 is a subtype of the influenza A virus. Its name derives from the forms of the two kinds of proteinson the surface of its coat, hemagglutinin（H） ａnd neuraminidase（N）. H3N2 exchanges genes for internal proteins with other influenza subtypes. H3N2 has tended to dominate in prevalence over H1N1, H1N2, ａnd influenza B. H3N2 strain descended from H2N2by antigenic shift, in which genes from multiple subtypes re-assorted to form a new virus. Both the H2N2and H3N2 strains contained genesfrom avian influenzaviruses. Description Recombinant Full-Length H3N2 A/New York/55/04 is glycosylated with N-linked sugars, produced using baculovirus vectors in insect cells ａnd its Mw is 70,000 dalton. Source Baculovirus Insect Cells. Physical Appearance Sterile Filtered colorless solution FormulationThe Recombinant H3N2 A/New-York/55/04 solution contains 30mM Sodium phosphate, pH 7.4 ａnd 500mM NaCl. Stability H3N2 A/New-York/55/04 Recombinant should be stored at 4°C. Immunological Activity Western-Blot 0.1μg -1μg per strip, ELISA 1μg/Well. Purity Greater than 90.0% as determined by SDS-PAGE. Usage ProSpec＇s products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
H3N2 New-York/重组血凝素A型流感病毒H3N2病毒New York 55/04
产品编号：IHA-011
产品规格：2μg/10μg/100μg
Introduction H3N2 is a subtype of the influenza A virus. Its name derives from the forms of the two kinds of proteinson the surface of its coat, hemagglutinin（H） ａnd neuraminidase（N）. H3N2 exchanges genes for internal proteins with other influenza subtypes. H3N2 has tended to dominate in prevalence over H1N1, H1N2, ａnd influenza B. H3N2 strain descended from H2N2by antigenic shift, in which genes from multiple subtypes re-assorted to form a new virus. Both the H2N2and H3N2 strains contained genesfrom avian influenzaviruses. Description Recombinant Full-Length H3N2 A/New York/55/04 is glycosylated with N-linked sugars, produced using baculovirus vectors in insect cells ａnd its Mw is 70,000 dalton. Source Baculovirus Insect Cells. Physical Appearance Sterile Filtered colorless solution FormulationThe Recombinant H3N2 A/New-York/55/04 solution contains 30mM Sodium phosphate, pH 7.4 ａnd 500mM NaCl. Stability H3N2 A/New-York/55/04 Recombinant should be stored at 4°C. Immunological Activity Western-Blot 0.1μg -1μg per strip, ELISA 1μg/Well. Purity Greater than 90.0% as determined by SDS-PAGE. Usage ProSpec＇s products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
H3N2 New-York/重组血凝素A型流感病毒H3N2病毒New York 55/04
产品编号：IHA-011
产品规格：2μg/10μg/100μg
Introduction H3N2 is a subtype of the influenza A virus. Its name derives from the forms of the two kinds of proteinson the surface of its coat, hemagglutinin（H） ａnd neuraminidase（N）. H3N2 exchanges genes for internal proteins with other influenza subtypes. H3N2 has tended to dominate in prevalence over H1N1, H1N2, ａnd influenza B. H3N2 strain descended from H2N2by antigenic shift, in which genes from multiple subtypes re-assorted to form a new virus. Both the H2N2and H3N2 strains contained genesfrom avian influenzaviruses. Description Recombinant Full-Length H3N2 A/New York/55/04 is glycosylated with N-linked sugars, produced using baculovirus vectors in insect cells ａnd its Mw is 70,000 dalton. Source Baculovirus Insect Cells. Physical Appearance Sterile Filtered colorless solution FormulationThe Recombinant H3N2 A/New-York/55/04 solution contains 30mM Sodium phosphate, pH 7.4 ａnd 500mM NaCl. Stability H3N2 A/New-York/55/04 Recombinant should be stored at 4°C. Immunological Activity Western-Blot 0.1μg -1μg per strip, ELISA 1μg/Well. Purity Greater than 90.0% as determined by SDS-PAGE. Usage ProSpec＇s products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
H3N2 New-York/重组血凝素A型流感病毒H3N2病毒New York 55/04
产品编号：IHA-011
产品规格：2μg/10μg/100μg
Introduction H3N2 is a subtype of the influenza A virus. Its name derives from the forms of the two kinds of proteinson the surface of its coat, hemagglutinin（H） ａnd neuraminidase（N）. H3N2 exchanges genes for internal proteins with other influenza subtypes. H3N2 has tended to dominate in prevalence over H1N1, H1N2, ａnd influenza B. H3N2 strain descended from H2N2by antigenic shift, in which genes from multiple subtypes re-assorted to form a new virus. Both the H2N2and H3N2 strains contained genesfrom avian influenzaviruses. Description Recombinant Full-Length H3N2 A/New York/55/04 is glycosylated with N-linked sugars, produced using baculovirus vectors in insect cells ａnd its Mw is 70,000 dalton. Source Baculovirus Insect Cells. Physical Appearance Sterile Filtered colorless solution FormulationThe Recombinant H3N2 A/New-York/55/04 solution contains 30mM Sodium phosphate, pH 7.4 ａnd 500mM NaCl. Stability H3N2 A/New-York/55/04 Recombinant should be stored at 4°C. Immunological Activity Western-Blot 0.1μg -1μg per strip, ELISA 1μg/Well. Purity Greater than 90.0% as determined by SDS-PAGE. Usage ProSpec＇s products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
H3N2 New-York/重组血凝素A型流感病毒H3N2病毒New York 55/04
产品编号：IHA-011
产品规格：2μg/10μg/100μg
Introduction H3N2 is a subtype of the influenza A virus. Its name derives from the forms of the two kinds of proteinson the surface of its coat, hemagglutinin（H） ａnd neuraminidase（N）. H3N2 exchanges genes for internal proteins with other influenza subtypes. H3N2 has tended to dominate in prevalence over H1N1, H1N2, ａnd influenza B. H3N2 strain descended from H2N2by antigenic shift, in which genes from multiple subtypes re-assorted to form a new virus. Both the H2N2and H3N2 strains contained genesfrom avian influenzaviruses. Description Recombinant Full-Length H3N2 A/New York/55/04 is glycosylated with N-linked sugars, produced using baculovirus vectors in insect cells ａnd its Mw is 70,000 dalton. Source Baculovirus Insect Cells. Physical Appearance Sterile Filtered colorless solution FormulationThe Recombinant H3N2 A/New-York/55/04 solution contains 30mM Sodium phosphate, pH 7.4 ａnd 500mM NaCl. Stability H3N2 A/New-York/55/04 Recombinant should be stored at 4°C. Immunological Activity Western-Blot 0.1μg -1μg per strip, ELISA 1μg/Well. Purity Greater than 90.0% as determined by SDS-PAGE. Usage ProSpec＇s products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
H3N2 New-York/重组血凝素A型流感病毒H3N2病毒New York 55/04
产品编号：IHA-011
产品规格：2μg/10μg/100μg
Introduction H3N2 is a subtype of the influenza A virus. Its name derives from the forms of the two kinds of proteinson the surface of its coat, hemagglutinin（H） ａnd neuraminidase（N）. H3N2 exchanges genes for internal proteins with other influenza subtypes. H3N2 has tended to dominate in prevalence over H1N1, H1N2, ａnd influenza B. H3N2 strain descended from H2N2by antigenic shift, in which genes from multiple subtypes re-assorted to form a new virus. Both the H2N2and H3N2 strains contained genesfrom avian influenzaviruses. Description Recombinant Full-Length H3N2 A/New York/55/04 is glycosylated with N-linked sugars, produced using baculovirus vectors in insect cells ａnd its Mw is 70,000 dalton. Source Baculovirus Insect Cells. Physical Appearance Sterile Filtered colorless solution FormulationThe Recombinant H3N2 A/New-York/55/04 solution contains 30mM Sodium phosphate, pH 7.4 ａnd 500mM NaCl. Stability H3N2 A/New-York/55/04 Recombinant should be stored at 4°C. Immunological Activity Western-Blot 0.1μg -1μg per strip, ELISA 1μg/Well. Purity Greater than 90.0% as determined by SDS-PAGE. Usage ProSpec＇s products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
H3N2 New-York/重组血凝素A型流感病毒H3N2病毒New York 55/04
产品编号：IHA-011
产品规格：2μg/10μg/100μg
Introduction H3N2 is a subtype of the influenza A virus. Its name derives from the forms of the two kinds of proteinson the surface of its coat, hemagglutinin（H） ａnd neuraminidase（N）. H3N2 exchanges genes for internal proteins with other influenza subtypes. H3N2 has tended to dominate in prevalence over H1N1, H1N2, ａnd influenza B. H3N2 strain descended from H2N2by antigenic shift, in which genes from multiple subtypes re-assorted to form a new virus. Both the H2N2and H3N2 strains contained genesfrom avian influenzaviruses. Description Recombinant Full-Length H3N2 A/New York/55/04 is glycosylated with N-linked sugars, produced using baculovirus vectors in insect cells ａnd its Mw is 70,000 dalton. Source Baculovirus Insect Cells. Physical Appearance Sterile Filtered colorless solution FormulationThe Recombinant H3N2 A/New-York/55/04 solution contains 30mM Sodium phosphate, pH 7.4 ａnd 500mM NaCl. Stability H3N2 A/New-York/55/04 Recombinant should be stored at 4°C. Immunological Activity Western-Blot 0.1μg -1μg per strip, ELISA 1μg/Well. Purity Greater than 90.0% as determined by SDS-PAGE. Usage ProSpec＇s products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
H3N2 New-York/重组血凝素A型流感病毒H3N2病毒New York 55/04
产品编号：IHA-011
产品规格：2μg/10μg/100μg
Introduction H3N2 is a subtype of the influenza A virus. Its name derives from the forms of the two kinds of proteinson the surface of its coat, hemagglutinin（H） ａnd neuraminidase（N）. H3N2 exchanges genes for internal proteins with other influenza subtypes. H3N2 has tended to dominate in prevalence over H1N1, H1N2, ａnd influenza B. H3N2 strain descended from H2N2by antigenic shift, in which genes from multiple subtypes re-assorted to form a new virus. Both the H2N2and H3N2 strains contained genesfrom avian influenzaviruses. Description Recombinant Full-Length H3N2 A/New York/55/04 is glycosylated with N-linked sugars, produced using baculovirus vectors in insect cells ａnd its Mw is 70,000 dalton. Source Baculovirus Insect Cells. Physical Appearance Sterile Filtered colorless solution FormulationThe Recombinant H3N2 A/New-York/55/04 solution contains 30mM Sodium phosphate, pH 7.4 ａnd 500mM NaCl. Stability H3N2 A/New-York/55/04 Recombinant should be stored at 4°C. Immunological Activity Western-Blot 0.1μg -1μg per strip, ELISA 1μg/Well. Purity Greater than 90.0% as determined by SDS-PAGE. Usage ProSpec＇s products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
H3N2 New-York/重组血凝素A型流感病毒H3N2病毒New York 55/04
产品编号：IHA-011
产品规格：2μg/10μg/100μg
Introduction H3N2 is a subtype of the influenza A virus. Its name derives from the forms of the two kinds of proteinson the surface of its coat, hemagglutinin（H） ａnd neuraminidase（N）. H3N2 exchanges genes for internal proteins with other influenza subtypes. H3N2 has tended to dominate in prevalence over H1N1, H1N2, ａnd influenza B. H3N2 strain descended from H2N2by antigenic shift, in which genes from multiple subtypes re-assorted to form a new virus. Both the H2N2and H3N2 strains contained genesfrom avian influenzaviruses. Description Recombinant Full-Length H3N2 A/New York/55/04 is glycosylated with N-linked sugars, produced using baculovirus vectors in insect cells ａnd its Mw is 70,000 dalton. Source Baculovirus Insect Cells. Physical Appearance Sterile Filtered colorless solution FormulationThe Recombinant H3N2 A/New-York/55/04 solution contains 30mM Sodium phosphate, pH 7.4 ａnd 500mM NaCl. Stability H3N2 A/New-York/55/04 Recombinant should be stored at 4°C. Immunological Activity Western-Blot 0.1μg -1μg per strip, ELISA 1μg/Well. Purity Greater than 90.0% as determined by SDS-PAGE. Usage ProSpec＇s products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
H3N2 New-York/重组血凝素A型流感病毒H3N2病毒New York 55/04
产品编号：IHA-011
产品规格：2μg/10μg/100μg
Introduction H3N2 is a subtype of the influenza A virus. Its name derives from the forms of the two kinds of proteinson the surface of its coat, hemagglutinin（H） ａnd neuraminidase（N）. H3N2 exchanges genes for internal proteins with other influenza subtypes. H3N2 has tended to dominate in prevalence over H1N1, H1N2, ａnd influenza B. H3N2 strain descended from H2N2by antigenic shift, in which genes from multiple subtypes re-assorted to form a new virus. Both the H2N2and H3N2 strains contained genesfrom avian influenzaviruses. Description Recombinant Full-Length H3N2 A/New York/55/04 is glycosylated with N-linked sugars, produced using baculovirus vectors in insect cells ａnd its Mw is 70,000 dalton. Source Baculovirus Insect Cells. Physical Appearance Sterile Filtered colorless solution FormulationThe Recombinant H3N2 A/New-York/55/04 solution contains 30mM Sodium phosphate, pH 7.4 ａnd 500mM NaCl. Stability H3N2 A/New-York/55/04 Recombinant should be stored at 4°C. Immunological Activity Western-Blot 0.1μg -1μg per strip, ELISA 1μg/Well. Purity Greater than 90.0% as determined by SDS-PAGE. Usage ProSpec＇s products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
H3N2 New-York/重组血凝素A型流感病毒H3N2病毒New York 55/04
产品编号：IHA-011
产品规格：2μg/10μg/100μg
Introduction H3N2 is a subtype of the influenza A virus. Its name derives from the forms of the two kinds of proteinson the surface of its coat, hemagglutinin（H） ａnd neuraminidase（N）. H3N2 exchanges genes for internal proteins with other influenza subtypes. H3N2 has tended to dominate in prevalence over H1N1, H1N2, ａnd influenza B. H3N2 strain descended from H2N2by antigenic shift, in which genes from multiple subtypes re-assorted to form a new virus. Both the H2N2and H3N2 strains contained genesfrom avian influenzaviruses. Description Recombinant Full-Length H3N2 A/New York/55/04 is glycosylated with N-linked sugars, produced using baculovirus vectors in insect cells ａnd its Mw is 70,000 dalton. Source Baculovirus Insect Cells. Physical Appearance Sterile Filtered colorless solution FormulationThe Recombinant H3N2 A/New-York/55/04 solution contains 30mM Sodium phosphate, pH 7.4 ａnd 500mM NaCl. Stability H3N2 A/New-York/55/04 Recombinant should be stored at 4°C. Immunological Activity Western-Blot 0.1μg -1μg per strip, ELISA 1μg/Well. Purity Greater than 90.0% as determined by SDS-PAGE. Usage ProSpec＇s products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
H3N2 New-York/重组血凝素A型流感病毒H3N2病毒New York 55/04
产品编号：IHA-011
产品规格：2μg/10μg/100μg
Introduction H3N2 is a subtype of the influenza A virus. Its name derives from the forms of the two kinds of proteinson the surface of its coat, hemagglutinin（H） ａnd neuraminidase（N）. H3N2 exchanges genes for internal proteins with other influenza subtypes. H3N2 has tended to dominate in prevalence over H1N1, H1N2, ａnd influenza B. H3N2 strain descended from H2N2by antigenic shift, in which genes from multiple subtypes re-assorted to form a new virus. Both the H2N2and H3N2 strains contained genesfrom avian influenzaviruses. Description Recombinant Full-Length H3N2 A/New York/55/04 is glycosylated with N-linked sugars, produced using baculovirus vectors in insect cells ａnd its Mw is 70,000 dalton. Source Baculovirus Insect Cells. Physical Appearance Sterile Filtered colorless solution FormulationThe Recombinant H3N2 A/New-York/55/04 solution contains 30mM Sodium phosphate, pH 7.4 ａnd 500mM NaCl. Stability H3N2 A/New-York/55/04 Recombinant should be stored at 4°C. Immunological Activity Western-Blot 0.1μg -1μg per strip, ELISA 1μg/Well. Purity Greater than 90.0% as determined by SDS-PAGE. Usage ProSpec＇s products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
H3N2 New-York/重组血凝素A型流感病毒H3N2病毒New York 55/04
产品编号：IHA-011
产品规格：2μg/10μg/100μg
Introduction H3N2 is a subtype of the influenza A virus. Its name derives from the forms of the two kinds of proteinson the surface of its coat, hemagglutinin（H） ａnd neuraminidase（N）. H3N2 exchanges genes for internal proteins with other influenza subtypes. H3N2 has tended to dominate in prevalence over H1N1, H1N2, ａnd influenza B. H3N2 strain descended from H2N2by antigenic shift, in which genes from multiple subtypes re-assorted to form a new virus. Both the H2N2and H3N2 strains contained genesfrom avian influenzaviruses. Description Recombinant Full-Length H3N2 A/New York/55/04 is glycosylated with N-linked sugars, produced using baculovirus vectors in insect cells ａnd its Mw is 70,000 dalton. Source Baculovirus Insect Cells. Physical Appearance Sterile Filtered colorless solution FormulationThe Recombinant H3N2 A/New-York/55/04 solution contains 30mM Sodium phosphate, pH 7.4 ａnd 500mM NaCl. Stability H3N2 A/New-York/55/04 Recombinant should be stored at 4°C. Immunological Activity Western-Blot 0.1μg -1μg per strip, ELISA 1μg/Well. Purity Greater than 90.0% as determined by SDS-PAGE. Usage ProSpec＇s products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
H3N2 New-York/重组血凝素A型流感病毒H3N2病毒New York 55/04
产品编号：IHA-011
产品规格：2μg/10μg/100μg
Introduction H3N2 is a subtype of the influenza A virus. Its name derives from the forms of the two kinds of proteinson the surface of its coat, hemagglutinin（H） ａnd neuraminidase（N）. H3N2 exchanges genes for internal proteins with other influenza subtypes. H3N2 has tended to dominate in prevalence over H1N1, H1N2, ａnd influenza B. H3N2 strain descended from H2N2by antigenic shift, in which genes from multiple subtypes re-assorted to form a new virus. Both the H2N2and H3N2 strains contained genesfrom avian influenzaviruses. Description Recombinant Full-Length H3N2 A/New York/55/04 is glycosylated with N-linked sugars, produced using baculovirus vectors in insect cells ａnd its Mw is 70,000 dalton. Source Baculovirus Insect Cells. Physical Appearance Sterile Filtered colorless solution FormulationThe Recombinant H3N2 A/New-York/55/04 solution contains 30mM Sodium phosphate, pH 7.4 ａnd 500mM NaCl. Stability H3N2 A/New-York/55/04 Recombinant should be stored at 4°C. Immunological Activity Western-Blot 0.1μg -1μg per strip, ELISA 1μg/Well. Purity Greater than 90.0% as determined by SDS-PAGE. Usage ProSpec＇s products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
H3N2 New-York/重组血凝素A型流感病毒H3N2病毒New York 55/04
产品编号：IHA-011
产品规格：2μg/10μg/100μg
Introduction H3N2 is a subtype of the influenza A virus. Its name derives from the forms of the two kinds of proteinson the surface of its coat, hemagglutinin（H） ａnd neuraminidase（N）. H3N2 exchanges genes for internal proteins with other influenza subtypes. H3N2 has tended to dominate in prevalence over H1N1, H1N2, ａnd influenza B. H3N2 strain descended from H2N2by antigenic shift, in which genes from multiple subtypes re-assorted to form a new virus. Both the H2N2and H3N2 strains contained genesfrom avian influenzaviruses. Description Recombinant Full-Length H3N2 A/New York/55/04 is glycosylated with N-linked sugars, produced using baculovirus vectors in insect cells ａnd its Mw is 70,000 dalton. Source Baculovirus Insect Cells. Physical Appearance Sterile Filtered colorless solution FormulationThe Recombinant H3N2 A/New-York/55/04 solution contains 30mM Sodium phosphate, pH 7.4 ａnd 500mM NaCl. Stability H3N2 A/New-York/55/04 Recombinant should be stored at 4°C. Immunological Activity Western-Blot 0.1μg -1μg per strip, ELISA 1μg/Well. Purity Greater than 90.0% as determined by SDS-PAGE. Usage ProSpec＇s products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
H3N2 New-York/重组血凝素A型流感病毒H3N2病毒New York 55/04
产品编号：IHA-011
产品规格：2μg/10μg/100μg
Introduction H3N2 is a subtype of the influenza A virus. Its name derives from the forms of the two kinds of proteinson the surface of its coat, hemagglutinin（H） ａnd neuraminidase（N）. H3N2 exchanges genes for internal proteins with other influenza subtypes. H3N2 has tended to dominate in prevalence over H1N1, H1N2, ａnd influenza B. H3N2 strain descended from H2N2by antigenic shift, in which genes from multiple subtypes re-assorted to form a new virus. Both the H2N2and H3N2 strains contained genesfrom avian influenzaviruses. Description Recombinant Full-Length H3N2 A/New York/55/04 is glycosylated with N-linked sugars, produced using baculovirus vectors in insect cells ａnd its Mw is 70,000 dalton. Source Baculovirus Insect Cells. Physical Appearance Sterile Filtered colorless solution FormulationThe Recombinant H3N2 A/New-York/55/04 solution contains 30mM Sodium phosphate, pH 7.4 ａnd 500mM NaCl. Stability H3N2 A/New-York/55/04 Recombinant should be stored at 4°C. Immunological Activity Western-Blot 0.1μg -1μg per strip, ELISA 1μg/Well. Purity Greater than 90.0% as determined by SDS-PAGE. Usage ProSpec＇s products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
H3N2 New-York/重组血凝素A型流感病毒H3N2病毒New York 55/04
产品编号：IHA-011
产品规格：2μg/10μg/100μg
Introduction H3N2 is a subtype of the influenza A virus. Its name derives from the forms of the two kinds of proteinson the surface of its coat, hemagglutinin（H） ａnd neuraminidase（N）. H3N2 exchanges genes for internal proteins with other influenza subtypes. H3N2 has tended to dominate in prevalence over H1N1, H1N2, ａnd influenza B. H3N2 strain descended from H2N2by antigenic shift, in which genes from multiple subtypes re-assorted to form a new virus. Both the H2N2and H3N2 strains contained genesfrom avian influenzaviruses. Description Recombinant Full-Length H3N2 A/New York/55/04 is glycosylated with N-linked sugars, produced using baculovirus vectors in insect cells ａnd its Mw is 70,000 dalton. Source Baculovirus Insect Cells. Physical Appearance Sterile Filtered colorless solution FormulationThe Recombinant H3N2 A/New-York/55/04 solution contains 30mM Sodium phosphate, pH 7.4 ａnd 500mM NaCl. Stability H3N2 A/New-York/55/04 Recombinant should be stored at 4°C. Immunological Activity Western-Blot 0.1μg -1μg per strip, ELISA 1μg/Well. Purity Greater than 90.0% as determined by SDS-PAGE. Usage ProSpec＇s products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
H3N2 New-York/重组血凝素A型流感病毒H3N2病毒New York 55/04
产品编号：IHA-011
产品规格：2μg/10μg/100μg
Introduction H3N2 is a subtype of the influenza A virus. Its name derives from the forms of the two kinds of proteinson the surface of its coat, hemagglutinin（H） ａnd neuraminidase（N）. H3N2 exchanges genes for internal proteins with other influenza subtypes. H3N2 has tended to dominate in prevalence over H1N1, H1N2, ａnd influenza B. H3N2 strain descended from H2N2by antigenic shift, in which genes from multiple subtypes re-assorted to form a new virus. Both the H2N2and H3N2 strains contained genesfrom avian influenzaviruses. Description Recombinant Full-Length H3N2 A/New York/55/04 is glycosylated with N-linked sugars, produced using baculovirus vectors in insect cells ａnd its Mw is 70,000 dalton. Source Baculovirus Insect Cells. Physical Appearance Sterile Filtered colorless solution FormulationThe Recombinant H3N2 A/New-York/55/04 solution contains 30mM Sodium phosphate, pH 7.4 ａnd 500mM NaCl. Stability H3N2 A/New-York/55/04 Recombinant should be stored at 4°C. Immunological Activity Western-Blot 0.1μg -1μg per strip, ELISA 1μg/Well. Purity Greater than 90.0% as determined by SDS-PAGE. Usage ProSpec＇s products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
H3N2 New-York/重组血凝素A型流感病毒H3N2病毒New York 55/04
产品编号：IHA-011
产品规格：2μg/10μg/100μg
Introduction H3N2 is a subtype of the influenza A virus. Its name derives from the forms of the two kinds of proteinson the surface of its coat, hemagglutinin（H） ａnd neuraminidase（N）. H3N2 exchanges genes for internal proteins with other influenza subtypes. H3N2 has tended to dominate in prevalence over H1N1, H1N2, ａnd influenza B. H3N2 strain descended from H2N2by antigenic shift, in which genes from multiple subtypes re-assorted to form a new virus. Both the H2N2and H3N2 strains contained genesfrom avian influenzaviruses. Description Recombinant Full-Length H3N2 A/New York/55/04 is glycosylated with N-linked sugars, produced using baculovirus vectors in insect cells ａnd its Mw is 70,000 dalton. Source Baculovirus Insect Cells. Physical Appearance Sterile Filtered colorless solution FormulationThe Recombinant H3N2 A/New-York/55/04 solution contains 30mM Sodium phosphate, pH 7.4 ａnd 500mM NaCl. Stability H3N2 A/New-York/55/04 Recombinant should be stored at 4°C. Immunological Activity Western-Blot 0.1μg -1μg per strip, ELISA 1μg/Well. Purity Greater than 90.0% as determined by SDS-PAGE. Usage ProSpec＇s products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
H3N2 New-York/重组血凝素A型流感病毒H3N2病毒New York 55/04
产品编号：IHA-011
产品规格：2μg/10μg/100μg
Introduction H3N2 is a subtype of the influenza A virus. Its name derives from the forms of the two kinds of proteinson the surface of its coat, hemagglutinin（H） ａnd neuraminidase（N）. H3N2 exchanges genes for internal proteins with other influenza subtypes. H3N2 has tended to dominate in prevalence over H1N1, H1N2, ａnd influenza B. H3N2 strain descended from H2N2by antigenic shift, in which genes from multiple subtypes re-assorted to form a new virus. Both the H2N2and H3N2 strains contained genesfrom avian influenzaviruses. Description Recombinant Full-Length H3N2 A/New York/55/04 is glycosylated with N-linked sugars, produced using baculovirus vectors in insect cells ａnd its Mw is 70,000 dalton. Source Baculovirus Insect Cells. Physical Appearance Sterile Filtered colorless solution FormulationThe Recombinant H3N2 A/New-York/55/04 solution contains 30mM Sodium phosphate, pH 7.4 ａnd 500mM NaCl. Stability H3N2 A/New-York/55/04 Recombinant should be stored at 4°C. Immunological Activity Western-Blot 0.1μg -1μg per strip, ELISA 1μg/Well. Purity Greater than 90.0% as determined by SDS-PAGE. Usage ProSpec＇s products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
H3N2 New-York/重组血凝素A型流感病毒H3N2病毒New York 55/04
产品编号：IHA-011
产品规格：2μg/10μg/100μg
Introduction H3N2 is a subtype of the influenza A virus. Its name derives from the forms of the two kinds of proteinson the surface of its coat, hemagglutinin（H） ａnd neuraminidase（N）. H3N2 exchanges genes for internal proteins with other influenza subtypes. H3N2 has tended to dominate in prevalence over H1N1, H1N2, ａnd influenza B. H3N2 strain descended from H2N2by antigenic shift, in which genes from multiple subtypes re-assorted to form a new virus. Both the H2N2and H3N2 strains contained genesfrom avian influenzaviruses. Description Recombinant Full-Length H3N2 A/New York/55/04 is glycosylated with N-linked sugars, produced using baculovirus vectors in insect cells ａnd its Mw is 70,000 dalton. Source Baculovirus Insect Cells. Physical Appearance Sterile Filtered colorless solution FormulationThe Recombinant H3N2 A/New-York/55/04 solution contains 30mM Sodium phosphate, pH 7.4 ａnd 500mM NaCl. Stability H3N2 A/New-York/55/04 Recombinant should be stored at 4°C. Immunological Activity Western-Blot 0.1μg -1μg per strip, ELISA 1μg/Well. Purity Greater than 90.0% as determined by SDS-PAGE. Usage ProSpec＇s products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
H3N2 New-York/重组血凝素A型流感病毒H3N2病毒New York 55/04
产品编号：IHA-011
产品规格：2μg/10μg/100μg
Introduction H3N2 is a subtype of the influenza A virus. Its name derives from the forms of the two kinds of proteinson the surface of its coat, hemagglutinin（H） ａnd neuraminidase（N）. H3N2 exchanges genes for internal proteins with other influenza subtypes. H3N2 has tended to dominate in prevalence over H1N1, H1N2, ａnd influenza B. H3N2 strain descended from H2N2by antigenic shift, in which genes from multiple subtypes re-assorted to form a new virus. Both the H2N2and H3N2 strains contained genesfrom avian influenzaviruses. Description Recombinant Full-Length H3N2 A/New York/55/04 is glycosylated with N-linked sugars, produced using baculovirus vectors in insect cells ａnd its Mw is 70,000 dalton. Source Baculovirus Insect Cells. Physical Appearance Sterile Filtered colorless solution FormulationThe Recombinant H3N2 A/New-York/55/04 solution contains 30mM Sodium phosphate, pH 7.4 ａnd 500mM NaCl. Stability H3N2 A/New-York/55/04 Recombinant should be stored at 4°C. Immunological Activity Western-Blot 0.1μg -1μg per strip, ELISA 1μg/Well. Purity Greater than 90.0% as determined by SDS-PAGE. Usage ProSpec＇s products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
H3N2 New-York/重组血凝素A型流感病毒H3N2病毒New York 55/04
产品编号：IHA-011
产品规格：2μg/10μg/100μg
Introduction H3N2 is a subtype of the influenza A virus. Its name derives from the forms of the two kinds of proteinson the surface of its coat, hemagglutinin（H） ａnd neuraminidase（N）. H3N2 exchanges genes for internal proteins with other influenza subtypes. H3N2 has tended to dominate in prevalence over H1N1, H1N2, ａnd influenza B. H3N2 strain descended from H2N2by antigenic shift, in which genes from multiple subtypes re-assorted to form a new virus. Both the H2N2and H3N2 strains contained genesfrom avian influenzaviruses. Description Recombinant Full-Length H3N2 A/New York/55/04 is glycosylated with N-linked sugars, produced using baculovirus vectors in insect cells ａnd its Mw is 70,000 dalton. Source Baculovirus Insect Cells. Physical Appearance Sterile Filtered colorless solution FormulationThe Recombinant H3N2 A/New-York/55/04 solution contains 30mM Sodium phosphate, pH 7.4 ａnd 500mM NaCl. Stability H3N2 A/New-York/55/04 Recombinant should be stored at 4°C. Immunological Activity Western-Blot 0.1μg -1μg per strip, ELISA 1μg/Well. Purity Greater than 90.0% as determined by SDS-PAGE. Usage ProSpec＇s products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
H3N2 New-York/重组血凝素A型流感病毒H3N2病毒New York 55/04
产品编号：IHA-011
产品规格：2μg/10μg/100μg
Introduction H3N2 is a subtype of the influenza A virus. Its name derives from the forms of the two kinds of proteinson the surface of its coat, hemagglutinin（H） ａnd neuraminidase（N）. H3N2 exchanges genes for internal proteins with other influenza subtypes. H3N2 has tended to dominate in prevalence over H1N1, H1N2, ａnd influenza B. H3N2 strain descended from H2N2by antigenic shift, in which genes from multiple subtypes re-assorted to form a new virus. Both the H2N2and H3N2 strains contained genesfrom avian influenzaviruses. Description Recombinant Full-Length H3N2 A/New York/55/04 is glycosylated with N-linked sugars, produced using baculovirus vectors in insect cells ａnd its Mw is 70,000 dalton. Source Baculovirus Insect Cells. Physical Appearance Sterile Filtered colorless solution FormulationThe Recombinant H3N2 A/New-York/55/04 solution contains 30mM Sodium phosphate, pH 7.4 ａnd 500mM NaCl. Stability H3N2 A/New-York/55/04 Recombinant should be stored at 4°C. Immunological Activity Western-Blot 0.1μg -1μg per strip, ELISA 1μg/Well. Purity Greater than 90.0% as determined by SDS-PAGE. Usage ProSpec＇s products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
H3N2 New-York/重组血凝素A型流感病毒H3N2病毒New York 55/04
产品编号：IHA-011
产品规格：2μg/10μg/100μg
Introduction H3N2 is a subtype of the influenza A virus. Its name derives from the forms of the two kinds of proteinson the surface of its coat, hemagglutinin（H） ａnd neuraminidase（N）. H3N2 exchanges genes for internal proteins with other influenza subtypes. H3N2 has tended to dominate in prevalence over H1N1, H1N2, ａnd influenza B. H3N2 strain descended from H2N2by antigenic shift, in which genes from multiple subtypes re-assorted to form a new virus. Both the H2N2and H3N2 strains contained genesfrom avian influenzaviruses. Description Recombinant Full-Length H3N2 A/New York/55/04 is glycosylated with N-linked sugars, produced using baculovirus vectors in insect cells ａnd its Mw is 70,000 dalton. Source Baculovirus Insect Cells. Physical Appearance Sterile Filtered colorless solution FormulationThe Recombinant H3N2 A/New-York/55/04 solution contains 30mM Sodium phosphate, pH 7.4 ａnd 500mM NaCl. Stability H3N2 A/New-York/55/04 Recombinant should be stored at 4°C. Immunological Activity Western-Blot 0.1μg -1μg per strip, ELISA 1μg/Well. Purity Greater than 90.0% as determined by SDS-PAGE. Usage ProSpec＇s products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
H3N2 New-York/重组血凝素A型流感病毒H3N2病毒New York 55/04
产品编号：IHA-011
产品规格：2μg/10μg/100μg
Introduction H3N2 is a subtype of the influenza A virus. Its name derives from the forms of the two kinds of proteinson the surface of its coat, hemagglutinin（H） ａnd neuraminidase（N）. H3N2 exchanges genes for internal proteins with other influenza subtypes. H3N2 has tended to dominate in prevalence over H1N1, H1N2, ａnd influenza B. H3N2 strain descended from H2N2by antigenic shift, in which genes from multiple subtypes re-assorted to form a new virus. Both the H2N2and H3N2 strains contained genesfrom avian influenzaviruses. Description Recombinant Full-Length H3N2 A/New York/55/04 is glycosylated with N-linked sugars, produced using baculovirus vectors in insect cells ａnd its Mw is 70,000 dalton. Source Baculovirus Insect Cells. Physical Appearance Sterile Filtered colorless solution FormulationThe Recombinant H3N2 A/New-York/55/04 solution contains 30mM Sodium phosphate, pH 7.4 ａnd 500mM NaCl. Stability H3N2 A/New-York/55/04 Recombinant should be stored at 4°C. Immunological Activity Western-Blot 0.1μg -1μg per strip, ELISA 1μg/Well. Purity Greater than 90.0% as determined by SDS-PAGE. Usage ProSpec＇s products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
H3N2 New-York/重组血凝素A型流感病毒H3N2病毒New York 55/04
产品编号：IHA-011
产品规格：2μg/10μg/100μg
Introduction H3N2 is a subtype of the influenza A virus. Its name derives from the forms of the two kinds of proteinson the surface of its coat, hemagglutinin（H） ａnd neuraminidase（N）. H3N2 exchanges genes for internal proteins with other influenza subtypes. H3N2 has tended to dominate in prevalence over H1N1, H1N2, ａnd influenza B. H3N2 strain descended from H2N2by antigenic shift, in which genes from multiple subtypes re-assorted to form a new virus. Both the H2N2and H3N2 strains contained genesfrom avian influenzaviruses. Description Recombinant Full-Length H3N2 A/New York/55/04 is glycosylated with N-linked sugars, produced using baculovirus vectors in insect cells ａnd its Mw is 70,000 dalton. Source Baculovirus Insect Cells. Physical Appearance Sterile Filtered colorless solution FormulationThe Recombinant H3N2 A/New-York/55/04 solution contains 30mM Sodium phosphate, pH 7.4 ａnd 500mM NaCl. Stability H3N2 A/New-York/55/04 Recombinant should be stored at 4°C. Immunological Activity Western-Blot 0.1μg -1μg per strip, ELISA 1μg/Well. Purity Greater than 90.0% as determined by SDS-PAGE. Usage ProSpec＇s products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
产品规格：2μg/10μg/100μg
| Introduction | H3N2 is a subtype of the influenza A virus. Its name derives from the forms of the two kinds of proteinson the surface of its coat, hemagglutinin（H） ａnd neuraminidase（N）. H3N2 exchanges genes for internal proteins with other influenza subtypes. H3N2 has tended to dominate in prevalence over H1N1, H1N2, ａnd influenza B. H3N2 strain descended from H2N2by antigenic shift, in which genes from multiple subtypes re-assorted to form a new virus. Both the H2N2and H3N2 strains contained genesfrom avian influenzaviruses. |
| Description | Recombinant Full-Length H3N2 A/New York/55/04 is glycosylated with N-linked sugars, produced using baculovirus vectors in insect cells ａnd its Mw is 70,000 dalton. |
| Source | Baculovirus Insect Cells. |
| Physical Appearance | Sterile Filtered colorless solution FormulationThe Recombinant H3N2 A/New-York/55/04 solution contains 30mM Sodium phosphate, pH 7.4 ａnd 500mM NaCl. |
| Stability | H3N2 A/New-York/55/04 Recombinant should be stored at 4°C. |
| Immunological Activity | Western-Blot 0.1μg -1μg per strip, ELISA 1μg/Well. |
| Purity | Greater than 90.0% as determined by SDS-PAGE. |
| Usage | ProSpec＇s products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals. |
